Chase Investment Counsel Corp Integra Lifesciences Holdings Corp Transaction History

Chase Investment Counsel Corp

  • $296 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 01, 2018
SELL
$57.63 - $65.87 $491,295 - $561,541
-8,525 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$54.05 - $67.23 $13,512 - $16,807
-250 Reduced 2.85%
8,525 $549,000
Q1 2018

May 07, 2018
BUY
$46.55 - $57.38 $408,476 - $503,509
8,775 New
8,775 $485,000

Others Institutions Holding IART

# of Institutions
241
Shares Held
75.3M
Call Options Held
585K
Put Options Held
21.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email